CSTF2-mediated 3'UTR shortening drives oncogenic activation of GPC3 in hepatocellular carcinoma. Jeon S, Shin E, Ha JW, Na MJ, et al. Oncogene 2026 Aug 10. doi: 10.1038/s41388-026-03937.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jeon S, Shin E, Ha JW, Na MJ, et al. CSTF2-mediated 3'UTR shortening drives oncogenic activation of GPC3 in hepatocellular carcinoma. Oncogene 2026 Aug 10. doi: 10.1038/s41388-026-03937.
PMID: 42575980